Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras is wildly overvalued after opening its debut up 102%, at about 157.8x sales. FY25 revenue was $510M against 215.23M shares outstanding, and its $150M net income was not related to its core business. Late buyers risk becoming bag holders. x.com  x.com 

Cerebras is now worth buying after its shares fell into the previously stated $60-$120 buying range. The earlier concern was an out-of-control valuation and providing liquidity to insiders at much higher prices; the shares shown are about $117. x.com 

Cerebras Systems is overpriced by retail buyers at around $400 a share, about 2.16 times its $185 IPO price. That price was set by the investment banks, management and institutional analysts, who know the business best, after the roadshow. x.com 

Cerebras likely needs more time despite heavy bullishness around its earnings and a nice breakout on its recent-IPO chart. Last quarter's earnings disappointed, so a sudden blowout quarter was unlikely. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras is not worth owning at about $90 billion in value on roughly $500 million of revenue. A post the author replies to adds that it has only two customers and argues investment banks are using retail investors for exit liquidity. x.com 

Cerebras is unattractive to buy at a valuation above $60 billion while its product remains unproven at scale. x.com 

Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com